粤万年青 (301111)

GUANGDONG LIFESTRONG PHARMACY CO., LTD.

ASZ

Tags

Face Mask ProtectionInfant and Child ConceptHelicobacter PyloriMicro and Small Cap StocksPlanned Reduction of HoldingsShareholder ReductionChinese Med. IISZSE Medicine Equal Weight IndexPharmaceutical IndexShenzhen A-Share Pharmaceutical IndexCSI All-share Pharmaceutical Sector IndexJune 2022 Lock-up ExpiryGuangdong

K-Line Chart

No K-line data available

Company NameGuangdong Wannianqing Pharmaceutical Co., Ltd.
Listing Date2021-12-07
Issue Price10.48RMB
Registered Capital1600010k RMB
Legal RepresentativeOu Xiantao
Registered AddressNo. 08, Block 16, Chaoyang Road, Jinyuan Industrial City, Shantou City, Guangdong Province
IndustryTraditional Chinese Medicine II
Main BusinessResearch, development, production, and sales of Chinese patent medicines.
Company ProfileGuangdong Wannianqing Pharmaceutical Co., Ltd., founded in 1951, is located in the beautiful coastal city of Shantou, Guangdong Province. After more than half a century of development, the company possesses a modern, large-scale production base compliant with GMP standards, along with 11 dosage form production lines and nearly a thousand sets of equipment. As a large modern pharmaceutical enterprise successively recognized as a "High-Tech Enterprise," "Guangdong Provincial Engineering Technology Research and Development Center," and "Guangdong Provincial Enterprise Technology Center," it boasts a wide variety of products and a complete range of dosage forms, including 102 nationally approved products across 11 dosage forms such as tablets, pills, small-volume injections, mixtures, and granules. Several products, including "Xiaoyan Lidan Tablets," "Danshitong Capsules," "Shilintong Tablets," and "Naolibao Pills," have received national and ministerial excellence awards. Products like "Yixin Pills," "Zhubei Dingchuan Pills," "Chuanxinlian Tablets," and "Danggui Buxue Liquid" have been awarded provincial excellence prizes. The "Wannianqing" trademark is recognized as a "Guangdong Famous Trademark." Adhering to the principle of being technology-driven and quality-focused for development, the company employs a dual approach of independent R&D innovation and collaboration with scientific research institutions. It has developed ten high-quality pharmaceutical production series, with core products focusing on biliary tract medications, cardiovascular medications, pediatric medications, and gynecological medications.

Stock Details

1. Key Indicators

  • Total Shares(W): 16000.00
  • Circulating A-Shares(W): 16000.00
  • Earnings Per Share(RMB): -0.0508
  • Net Assets Per Share(RMB): 4.6763
  • Operating Revenue(W RMB): 22841.49
  • Total Profit(W RMB): -1487.74
  • Net Profit Attributable to Parent(W RMB): -812.95
  • Net Profit Growth Rate(%): -157.65
  • Weighted Return on Equity(%): -1.0700
  • Operating Cash Flow Per Share(RMB): -0.0110
  • Undistributed Profit Per Share(RMB): 0.9190
  • Capital Reserve Per Share(RMB): 2.5434

2. Main Business

The main business covers:

  • Research, development, production, and sales of pharmaceuticals

3. Company Basic Information

  • Company Name: Guangdong Lifestrong Pharmacy Co., Ltd.
  • Listing Date: 2021-12-07
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 08, Block 16, Chaoyang Road, Jinyuan Industrial City, Shantou City, Guangdong Province
  • Website: www.wnqzy.com.cn
  • Company Profile: On July 2, 2018, Wannianqing Limited held a shareholders' meeting. All shareholders of Wannianqing Limited, acting as promoters, signed the "Sponsorship Agreement for Guangdong Lifestrong Pharmacy Co., Ltd. (in preparation)", agreeing to transform the company into Guangdong Lifestrong Pharmacy Co., Ltd. Based on the audited net assets as of May 31, 2018, the company was converted into 120 million shares, with the balance credited to capital reserve, establishing Guangdong Lifestrong Pharmacy Co., Ltd. On August 6, 2018, the company obtained the business license (No. 9144050019272917XC) issued by the Shantou Administration for Market Regulation.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Guangdong Jinou Health Technology Co., Ltd. General Legal Person 7200.00 45.00
2 Guangdong Qiaoyin Real Estate Development Co., Ltd. General Legal Person 1200.00 7.50
3 Hehe Investment Holding (Guangzhou) Partnership Enterprise (Limited Partnership) General Legal Person 1120.00 7.00
4 Shantou Yinkang Enterprise Management Consulting Partnership Enterprise (Limited Partnership) General Legal Person 397.74 2.49
5 Guangdong Small and Medium Enterprise Equity Investment Fund Co., Ltd. General Legal Person 349.37 2.18
6 MORGAN STANLEY & CO. INTERNATIONAL PLC. QFII 121.23 0.76
7 Goldman Sachs International - Proprietary Funds QFII 65.80 0.41
8 Shenzhen Qianhai Oriental Yinshi Asset Management Co., Ltd. - Xinyu Yinshi No.8 Investment Management Partnership (Limited Partnership) General Legal Person 53.00 0.33
9 J. P. Morgan Securities PLC - Proprietary Funds QFII 49.33 0.31

5. Concept Sectors

  • Infant and Child Concept
  • Elderly Care Concept
  • Mask Protection
  • Helicobacter Pylori
  • Innovative Drugs
  • Margin Trading and Securities Lending
  • Shareholder Reduction
  • Recent Weakness
  • Planned Reduction
  • Micro and Small Cap Stocks

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information